In Canada, 4500 people are diagnosed with Kidney Cancer and 1 in 3 die of the disease. It is the most lethal genitourinary cancer and its incidence is increasing. Unlike most human cancers, there is considerable knowledge about specific genetic changes in these cancers. Major advances in treatment are being made due to new systematic targeted therapies as well as less morbid technologies for localised cancers.
The 1st Canadian Kidney Cancer Forum was held in January 31 – February 2, 2008 in Mont Tremblant, Quebec.
Date: Feb 27th – March 1st , 2025
Location: Sheraton Gateway International Airport Hotel, Toronto
Discussed state-of-the-art RCC care and management
Explored and promoted research opportunities in kidney cancer within Canada
Networked and collaborated with national and international RCC experts
The Kidney Cancer Research Network of Canada is a virtual and inclusive network of researchers committed to the facilitation of kidney cancer research across different sites in Canada that will enhance the knowledge of kidney cancer and its treatment.
JOIN OUR NEWSLETTER
Dr. Bossé is a Medical Oncologist specializing in Genitourinary cancers, with a particular focus on kidney cancer. He earned his medical degree, Master’s in Physiology and Biophysics, and completed his Internal Medicine training at Université de Sherbrooke in Québec. Dr. Bossé completed his Medical Oncology residency at the University of Ottawa in 2016, followed by a clinical research fellowship at Dana-Farber Cancer Institute in Boston and a Master of Public Health from the Harvard T.H. Chan School of Public Health. He currently practices at The Ottawa Hospital Cancer Centre and serves as an Assistant Professor at the University of Ottawa.
Dr. Bimal Bhindi is a urologic oncologist and a fellow of the Royal College of Physicians and Surgeons of Canada. After obtaining a Diploma of College Studies through the Honours Science Program at John Abbott College, he went on to earn his medical degree at McGill University. He then completed residency training at the University of Toronto and obtained his Royal College Specialist certificate in Urology. During his residency training, he also completed the Royal College Clinical Investigator Program and obtained a master’s degree in clinical Epidemiology and Health Care Research. Following his residency, he completed urologic oncology fellowship training at Mayo Clinic (Rochester, MN, USA). He was subsequently recruited in 2018 to the Southern Alberta Institute of Urology and now focuses on all areas of urologic oncology, particularly prostate and kidney cancer. He uses open, laparoscopic-assisted and robotic-assisted surgical approaches.
Dr. Bhindi has been extensively involved in clinical outcomes, health services, and translational research. His research interests include active surveillance, optimization of patient selection for local therapies, personalized medicine, and multimodal therapy for advanced and metastatic prostate and kidney cancer. To date, he has authored 42 peer-reviewed manuscripts, a textbook chapter (Diagnosis and Surgical Management of Renal Tumors), 12 editorials, and has presented his work at numerous national and international conferences with multiple best presentation/poster awards.
Dr. Bhindi has also received various recognitions and awards, including the Conquer Cancer Foundation of the American Society of Clinical Oncology Merit Award, the Royal College of Physicians and Surgeons of Canada Detweiler Traveling Fellowship, the Claire Bombardier Master of Science award for most promising future scientist in the Clinical Epidemiology and Health Care Research program, the Queen Elizabeth II / William Kerr Scholarship in Science and Technology, the Dr. Clarke K. McLeod Memorial Scholarship, the J.W. McConnell Scholarship, the Canadian Institute of Health Research (CIHR) – Rx&D Health Research Foundation Summer Research Award, and the “Fonds de la Recherche en Santé du Québec”(FRSQ) Summer Research Award. He has also been recognized by European Urology, the Journal of Urology, and the Canadian Urological Association Journal with awards for his work as a peer-reviewer for these medical journals. Additionally, he was also the Valedictorian of his graduating class at John Abbott College and was awarded the Governor General’s Academic Medal.
